{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:39:01Z","timestamp":1791283141681,"version":"4.1.0"},"reference-count":15,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2014,4,9]],"date-time":"2014-04-09T00:00:00Z","timestamp":1397001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Int Assoc Provid AIDS Care"],"published-print":{"date-parts":[[2014,7]]},"abstract":"\n Design:<\/jats:title>\n Few global studies have assessed HIV clinician\u2013patient communication regarding cardiovascular disease (CVD) risks.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n We conducted a multicountry, comparative, cross-sectional survey of HIV-infected individuals in 12 countries on 5 continents in 2010, with 100 to 200 enrollees per country. HIV-infected adults >17 years and on antiretroviral therapy were recruited in clinics and community organizations and surveyed via direct interview, telephone encounter, or online. Chi-square analyses were performed with an 80% power to detect a difference of >20%.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n Of 2035 participants, 37% were women. Prevalence of self-reported CVD risk factors was 28% overall, and greater CVD risk was present in 55% of patients in North America, 12% in Africa, and 26% to 28% on other continents. Only 19% of patients ever discussed CVD with their physician, and 31% had ever discussed hypertension, hypercholesterolemia, family history of CVD, or smoking; these findings were true for HIV clinicians in all regions of the world. Forty-four percent of smokers reported never discussing smoking with their HIV clinician.<\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n We found that HIV clinicians worldwide are not sufficiently addressing CVD risk factors with their patients. Expanded training and education for HIV clinicians should include effective approaches to the mitigation of CV risk factors.<\/jats:p>\n <\/jats:sec>","DOI":"10.1177\/2325957414530473","type":"journal-article","created":{"date-parts":[[2014,4,10]],"date-time":"2014-04-10T02:26:06Z","timestamp":1397096766000},"page":"342-345","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":23,"title":["HIV Provider\u2013Patient Communication Regarding Cardiovascular Risk"],"prefix":"10.1177","volume":"13","author":[{"given":"Renslow","family":"Sherer","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Chicago, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suniti","family":"Solomon","sequence":"additional","affiliation":[{"name":"Center for AIDS Research and Education (YRG CARE), Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Schechter","sequence":"additional","affiliation":[{"name":"Federal University of Rio je Janeiro, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean B.","family":"Nachega","sequence":"additional","affiliation":[{"name":"Department of Medicine and Centre for Infectious Diseases, Faculty of Health Sciences, Stellenbosch University, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurgen","family":"Rockstroh","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M.","family":"Zuniga","sequence":"additional","affiliation":[{"name":"International Association of Physicians in AIDS Care (IAPAC), Chicago and Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2014,4,9]]},"reference":[{"key":"bibr1-2325957414530473","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200305230-00010"},{"key":"bibr2-2325957414530473","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062360"},{"key":"bibr3-2325957414530473","unstructured":"Lichtenstein K, Armon C, Bucharcz K, Analysis of cardiovascular risk factors in the HIV outpatient study cohort. [Abstract 755]. Presented at: 13th Conference on Retroviruses and Opportunistic Infections (CROI); February 5-8, 2006; Denver, CO."},{"key":"bibr4-2325957414530473","unstructured":"Panel on the Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. March 16, 2012;1\u2013166. http:\/\/www.aidsinfo.nih.gov\/ContentFiles\/AdultandAdolescentGL.pdf. Accessed February 27, 2012."},{"issue":"5","key":"bibr5-2325957414530473","first-page":"169","volume":"19","author":"Post WS","year":"2011","journal-title":"Top Antivir Med"},{"key":"bibr6-2325957414530473","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1004"},{"key":"bibr7-2325957414530473","unstructured":"Lumeck N, Dedes N, Pozniak A, European union guidelines for the clinical management and treatment of HIV infected adults in Europe. Version 5; 2009."},{"key":"bibr8-2325957414530473","volume-title":"British HIV Association Guidelines for the Treatment of HIV infected adults with Antiretroviral therapy","author":"Gazzard BG on behalf of the BHIVA Treatment Guidelines Working Group","year":"2008"},{"key":"bibr9-2325957414530473","doi-asserted-by":"publisher","DOI":"10.1086\/605292"},{"key":"bibr10-2325957414530473","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2011-050160"},{"key":"bibr11-2325957414530473","doi-asserted-by":"publisher","DOI":"10.1177\/1545109712437244"},{"key":"bibr12-2325957414530473","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e3182160726"},{"key":"bibr13-2325957414530473","unstructured":"Petoumenos K, Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the DAD study. Presented at: 17th Conference on Retroviruses and Opportunistic Infections [Abstract 124]. San Francisco, CA; 2010."},{"key":"bibr14-2325957414530473","unstructured":"Schroeder SA, Meriwether M. Smoking cessation: strategies for the HIV practitioner. IAS-USA Cases on the Web. http:\/\/www.iasusa.org\/cow\/cow-instructions.php?cowid=185. Accessed November 4, 2013."},{"key":"bibr15-2325957414530473","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0b013e328344556e"}],"container-title":["Journal of the International Association of Providers of AIDS Care (JIAPAC)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2325957414530473","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2325957414530473","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2325957414530473","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:53:16Z","timestamp":1777503196000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/2325957414530473"}},"subtitle":["Results from the 2010 AIDS Treatment for Life International Survey"],"short-title":[],"issued":{"date-parts":[[2014,4,9]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["10.1177\/2325957414530473"],"URL":"https:\/\/doi.org\/10.1177\/2325957414530473","relation":{},"ISSN":["2325-9582","2325-9582"],"issn-type":[{"value":"2325-9582","type":"print"},{"value":"2325-9582","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,9]]}}}